Skip to main content

68th Annual Scientific Meeting Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Red Recording

Sig Meeting

64 Views

Therapeutics (Industry)

(T 6) In vitro Profile of Elismetrep: A Potent and Highly Selective Blocker of the Migraine-Associated Channel TRPM8

Presenting Author(s)

JK

Justine Kupferman, PhD

Director of Neuroscience
Kallyope
New York, NY, United States

Non-presenting Author(s)

IS

Iyassu Sebhat, n/a

Kallyope, United States
BK

Bunpei Kakinoki, n/a

Tanabe Pharma Corporation
Chiyoda-ku, Tokyo, Japan
BL

Brett Lauring, M.D., Ph.D.

Chief Medical Officer
Kallyope, Inc.
New York, New York, United States